Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Dow
McKinsey
Mallinckrodt
Harvard Business School

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Patent: 5,952,547

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 5,952,547
Title: Modified Bacillus thuringiensis genes with improved expression in plant cells, methods of production on and use
Abstract:The invention relates to modified Bacillus thurigiensis genes with improved expression in plant cells, their preparation and uses. The invention relates more particularly to DNA fragments encoding all or part of a Bt insecticidal crystal protein, modified by translationally neutral modification(s) in cryptic promoter(s) and/or abortive intron(s). The invention also discloses method of preparing such modified DNAs, and methods of protecting plants from an insect pest.
Inventor(s): Cornelissen; Marc (Heusden, BE), Soetaert; Piet (Laarne, BE), Stam; Maike (Al Amstelveen, NL), Dockx; Jan (Turnhout, BE), Van Aarssen; Roel (Gent, BE)
Assignee: Plant Genetic Systems, N.V. (Brussels, BE)
Application Number:08/232,016
Patent Claims:see list of patent claims

Details for Patent 5,952,547

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Plant Genetic Systems, N.V. (Brussels, BE) 2016-09-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Plant Genetic Systems, N.V. (Brussels, BE) 2016-09-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Plant Genetic Systems, N.V. (Brussels, BE) 2016-09-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
Medtronic
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.